Evaluation of total hip replacement arthroplasties.
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects; D001178:Arthroplasty / Q000009:adverse effects; D001843:Bone Cements / Q000009:adverse effects; D002543:Cerebral Hemorrhage / Q000209:etiology; D005069:Evaluation Studies as Topic; D005260:Female; D005264:Femoral Fractures / Q000209:etiology; D006615:Hip / Q000601:surgery*; D006617:Hip Dislocation / Q000209:etiology; D006621:Hip Joint; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007087:Illinois; D007595:Joint Prosthesis; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D011183:Postoperative Complications; D011655:Pulmonary Embolism / Q000209:etiology; D013530:Surgical Wound Infection / Q000209:etiology; D013924:Thrombophlebitis / Q000209:etiology; D014552:Urinary Tract Infections / Q000209:etiology
D000925:Anticoagulants; D001843:Bone Cements